The Single and Double Blood Injection Rabbit Subarachnoid Hemorrhage Model

Translational Stroke Research

Volumn 6, Issue 1, 2015, Pages 88-97

  Kikkawa, Yuichiro ^a,b   Kurogi, Ryota ^a   Sasaki, Tomio ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

Animal model; Cerebral vasospasm; Cisterna magna; Rabbit; Subarachnoid hemorrhage

Indexed keywords

ANESTHETIC AGENT; KETAMINE;

ANALGESIA; ANESTHESIA; CISTERNA MAGNA; DISEASE MODEL; DOUBLE BLOOD INJECTION SUBARACHNOID HEMORRHAGE; EXPERIMENTAL RABBIT; EXPERIMENTAL STROKE; HUMAN; MEDICAL HISTORY; MORTALITY; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SINGLE BLOOD INJECTION SUBARACHNOID HEMORRHAGE; SUBARACHNOID HEMORRHAGE; ANIMAL; COMPLICATION; PATHOPHYSIOLOGY; RABBIT; VASOSPASM, INTRACRANIAL;

ANIMALS; CISTERNA MAGNA; DISEASE MODELS, ANIMAL; RABBITS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84922074360     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-014-0375-5     Document Type: Review

References (105)

1. Offerhaus L, van Gool J. Electrocardiographic changes and tissue catecholamines in experimental subarachnoid haemorrhage. Cardiovasc Res. 1969;3(4):433–40.
2. Svendgaard NA, Edvinsson L, Owman C, Sahlin C. Increased sensitivity of the basilar artery to norepinephrine and 5-hydroxytryptamine following experimental subarachnoid hemorrhage. Surg Neurol. 1977;8(3):191–5.
3. Edvinsson L, Egund N, Owman C, Sahlin C, Svendgaard NA. Reduced noradrenaline uptake and retention in cerebrovascular nerves associated with angiographically visible vasoconstriction following experimental subarachnoid hemorrhage in rabbits. Brain Res Bull. 1982;9(1–6):799–805.
4. Chan RC, Durity FA, Thompson GB, Nugent RA, Kendall M. The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit. J Neurosurg. 1984;61(6):1120–8. doi:10.3171/jns.1984.61.6.1120.
5. Liszczak TM, Black PM, Tzouras A, Foley L, Zervas NT. Morphological changes of the basilar artery, ventricles, and choroid plexus after experimental SAH. J Neurosurg. 1984;61(3):486–93. doi:10.3171/jns.1984.61.3.0486.
6. Nakano Y, Rumbaugh CL, Wang AM, Zamani AA, Colucci V. Experimental treatment of cerebral vascular spasm secondary to subarachnoid hemorrhage. Radiat Med. 1983;1(4):299–304.
7. Svendgaard NA, Edvinsson L, Owman C. Changes in sensitivity of cerebral vessels to noradrenaline and 5-hydroxytryptamine in the presence of subarachnoid blood. Acta Physiol Scand Suppl. 1977;452:73–5.
8. Gules I, Satoh M, Clower BR, Nanda A, Zhang JH. Comparison of three rat models of cerebral vasospasm. Am J Physiol Heart Circ Physiol. 2002;283(6):H2551–9. doi:10.1152/ajpheart.00616.2002.
9. Baker KF, Zervas NT, Pile-Spellman J, Vacanti FX, Miller D. Angiographic evidence of basilar artery constriction in the rabbit: a new model of vasospasm. Surg Neurol. 1987;27(2):107–12.
10. Endo S, Branson PJ, Alksne JF. Experimental model of symptomatic vasospasm in rabbits. Stroke. 1988;19(11):1420–5.
11. Marbacher S, Fandino J, Kitchen ND. Standard intracranial in vivo animal models of delayed cerebral vasospasm. Br J Neurosurg. 2010;24(4):415–34. doi:10.3109/02688691003746274.
12. Spallone A, Pastore FS. Cerebral vasospasm in a double-injection model in rabbit. Surg Neurol. 1989;32(6):408–17.
13. Zhou ML, Shi JX, Zhu JQ, Hang CH, Mao L, Chen KF, et al. Comparison between one- and two-hemorrhage models of cerebral vasospasm in rabbits. J Neurosci Methods. 2007;159(2):318–24. doi:10.1016/j.jneumeth.2006.07.026.
14. Bunc G, Kovacic S, Strnad S. Attenuation of cerebral vasospasm in rabbits using clonidine hydrochloride, a central adrenergic agonist. Auton Neurosci. 2003;105(1):71–6. doi:10.1016/S1566-0702(03)00003-1.
15. Naraoka M, Munakata A, Matsuda N, Shimamura N, Ohkuma H. Suppression of the Rho/Rho-Kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit. Transl Stroke Res. 2013;4(3):368–74. doi:10.1007/s12975-012-0247-9.
16. Song JN, Chen H, Zhang M, Zhao YL, Ma XD. Dynamic change in cerebral microcirculation and focal cerebral metabolism in experimental subarachnoid hemorrhage in rabbits. Metab Brain Dis. 2013;28(1):33–43. doi:10.1007/s11011-012-9369-8.
17. Nakajima M, Date I, Takahashi K, Ninomiya Y, Asari S, Ohmoto T. Effects of aging on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke. 2001;32(3):620–8.
18. McGirt MJ, Pradilla G, Legnani FG, Thai QA, Recinos PF, Tamargo RJ, et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery. 2006;58(5):945–51. doi:10.1227/01.NEU.0000210262.67628.7E. discussion −51.
19. Cosar M, Eser O, Fidan H, Sahin O, Buyukbas S, Ela Y, et al. The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. Surg Neurol. 2009;71(1):54–9. doi:10.1016/j.surneu.2007.08.020. discussion 9.
20. Fathi AR, Marbacher S, Graupner T, Wehrli F, Jakob SM, Schroth G, et al. Continuous intrathecal glyceryl trinitrate prevents delayed cerebral vasospasm in the single-SAH rabbit model in vivo. Acta Neurochir (Wien). 2011;153(8):1669–75. doi:10.1007/s00701-011-1049-7. discussion 75.
21. Debdi M, Seylaz J, Sercombe R. Early changes in rabbit cerebral artery reactivity after subarachnoid hemorrhage. Stroke. 1992;23(8):1154–62.
22. Gomis P, Tran-Dinh YR, Sercombe C, Sercombe R. Dexamethasone preventing contractile and cytoskeletal protein changes in the rabbit basilar artery after subarachnoid hemorrhage. J Neurosurg. 2005;102(4):715–20. doi:10.3171/jns.2005.102.4.0715.
23. Tran Dinh YR, Jomaa A, Callebert J, Reynier-Rebuffel AM, Tedgui A, Savarit A, et al. Overexpression of cyclooxygenase-2 in rabbit basilar artery endothelial cells after subarachnoid hemorrhage. Neurosurgery. 2001;48(3):626–33. discussion 33–5.
24. Roux S, Clozel M, Wolfgang R, Sprecher U, Clozel JP. Comparative evaluation of acute cerebral vasospasm by the microsphere and the angiography techniques. J Neurosci Methods. 1995;59(2):245–52.
25. Visocchi M, Di Rocco F, Ciampini A, Di Muro L. A new animal model for monitoring the early cerebral vasospasm after subarachnoid haemorrhage. J Neurosurg Sci. 2006;50(4):89–94.
26. Kawada S, Kinugasa K, Meguro T, Hirotsune N, Tokunaga K, Kamata I, et al. Experimental study of intracisternal administration of tissue-type plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid haemorrhage. Acta Neurochir (Wien). 1999;141(12):1331–8.
27. Bunc G, Kovacic S, Strnad S. Evaluation of functional response of cerebral arteries by a new morphometric technique. Auton Neurosci. 2001;93(1–2):41–7. doi:10.1016/S1566-0702(01)00327-7.
28. Kovacic S, Bunc G, Ravnik J. Correspondence between the time course of cerebral vasospasm and the level of cerebral dopamine-beta-hydroxylase in rabbits. Auton Neurosci. 2006;130(1–2):28–31. doi:10.1016/j.autneu.2006.05.002.
29. Mapara M, Thomas BS, Bhat KM. Rabbit as an animal model for experimental research. Dent Res J (Isfahan). 2012;9(1):111–8. doi:10.4103/1735-3327.92960.
30. Fukami M, Tani E, Takai A, Yamaura I, Minami N. Activity of smooth muscle phosphatases 1 and 2A in rabbit basilar artery in vasospasm. Stroke. 1995;26(12):2321–7.
31. Nakagomi T, Kassell NF, Sasaki T, Lehman RM, Hongo K, Ogawa H, et al. Time course of the blood-arterial wall barrier disruption following experimental subarachnoid haemorrhage. Acta Neurochir (Wien). 1989;98(3–4):176–83.
32. Chen G, Zhang S, Shi J, Ai J, Hang C. Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage. Cytokine. 2009;45(3):162–8. doi:10.1016/j.cyto.2008.11.015.
33. Fang Q, Chen G, Zhu W, Dong W, Wang Z. Influence of melatonin on cerebrovascular proinflammatory mediators expression and oxidative stress following subarachnoid hemorrhage in rabbits. Mediators Inflamm. 2009;2009:426346. doi:10.1155/2009/426346.
34. Li S, Xue J, Shi J, Yin H, Zhang Z. Combinatorial administration of insulin and vitamin C alleviates the cerebral vasospasm after experimental subarachnoid hemorrhage in rabbit. BMC Neurosci. 2011;12:77. doi:10.1186/1471-2202-12-77.
35. Zhuang Z, Zhou ML, You WC, Zhu L, Ma CY, Sun XJ, et al. Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits. BMC Neurosci. 2012;13:47. doi:10.1186/1471-2202-13-47.
36. Johshita H, Kassell NF, Sasaki T, Ogawa H. Impaired capillary perfusion and brain edema following experimental subarachnoid hemorrhage: a morphometric study. J Neurosurg. 1990;73(3):410–7. doi:10.3171/jns.1990.73.3.0410.
37. Marbacher S, Neuschmelting V, Graupner T, Jakob SM, Fandino J. Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo. Intensive Care Med. 2008;34(5):932–8. doi:10.1007/s00134-008-0995-x.
38. Neuschmelting V, Marbacher S, Fathi AR, Jakob SM, Fandino J. Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits. Acta Neurochir (Wien). 2009;151(7):795–801. doi:10.1007/s00701-009-0350-1. discussion −2.
39. Nihei H, Kassell NF, Dougherty DA, Sasaki T. Does vasospasm occur in small pial arteries and arterioles of rabbits? Stroke. 1991;22(11):1419–25.
40. Pasqualin A, Tsukahara T, Kassell NF, Torner JC. Effect of nicardipine on basilar artery vasoactive responses after subarachnoid hemorrhage. Neurosurgery. 1992;31(4):697–703. discussion −4.
41. Vollmer DG, Hongo K, Kassell NF, Ogawa H, Tsukahara T, Lehman RM. Effect of intracisternal antithrombin III on subarachnoid hemorrhage-induced arterial narrowing. J Neurosurg. 1989;70(4):599–604. doi:10.3171/jns.1989.70.4.0599.
42. Zuccarello M, Marsch JT, Schmitt G, Woodward J, Anderson DK. Effect of the 21-aminosteroid U-74006 F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg. 1989;71(1):98–104. doi:10.3171/jns.1989.71.1.0098.
43. Erdi MF, Guney O, Kiyici A, Esen H. The effects of alpha lipoic acid on cerebral vasospasm following experimental subarachnoid hemorrhage in the rabbit. Turk Neurosurg. 2011;21(4):527–33. doi:10.5137/1019-5149.JTN. 4431-11.1.
44. Firat MM, Gelebek V, Orer HS, Belen D, Firat AK, Balkanci F. Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model. AJNR Am J Neuroradiol. 2005;26(6):1357–62.
45. Guney O, Erdi F, Esen H, Kiyici A, Kocaogullar Y. N-acetylcysteine prevents vasospasm after subarachnoid hemorrhage. World Neurosurg. 2010;73(1):42–9. doi:10.1016/j.surneu.2009.06.003. discussion e3.
46. Miller CA, Lombard FW, Wu CT, Hubbard CJ, Silbajoris L, Borel CO, et al. Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy. Neurocrit Care. 2006;5(3):215–21. doi:10.1385/NCC:5:3:215.
47. Seckin H, Simsek S, Ozturk E, Yigitkanli K, Ozen O, Besalti O, et al. Topiramate attenuates hippocampal injury after experimental subarachnoid hemorrhage in rabbits. Neurol Res. 2009;31(5):490–5. doi:10.1179/016164108X339369.
48. Alafaci C, Salpietro F, Grasso G, Sfacteria A, Passalacqua M, Morabito A, et al. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur J Pharmacol. 2000;406(2):219–25.
49. Aydin MV, Caner H, Sen O, Ozen O, Atalay B, Cekinmez M, et al. Effect of melatonin on cerebral vasospasm following experimental subarachnoid hemorrhage. Neurol Res. 2005;27(1):77–82. doi:10.1179/016164105X18331.
50. Barbosa MD, Arthur AS, Louis RH, MacDonald T, Polin RS, Gazak C, et al. The novel 5-lipoxygenase inhibitor ABT-761 attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Neurosurgery. 2001;49(5):1205–12. discussion 12–3.
51. Buemi M, Grasso G, Corica F, Calapai G, Salpietro FM, Casuscelli T, et al. In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage. Eur J Pharmacol. 2000;392(1–2):31–4.
52. Foley PL, Caner HH, Kassell NF, Lee KS. Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery. 1994;34(1):108–12. discussion 12–3.
53. Grasso G, Passalacqua M, Sfacteria A, Conti A, Morabito A, Mazzullo G, et al. Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage? J Neurosurg. 2002;96(3):565–70. doi:10.3171/jns.2002.96.3.0565.
54. 2+ sensitivity contributes to increased vascular reactiveness after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2010;30(9):1637–50. doi:10.1038/jcbfm.2010.35.
55. Sen O, Caner H, Aydin MV, Ozen O, Atalay B, Altinors N, et al. The effect of mexiletine on the level of lipid peroxidation and apoptosis of endothelium following experimental subarachnoid hemorrhage. Neurol Res. 2006;28(8):859–63. doi:10.1179/016164106X115099.
56. Takahashi S, Kassell NF, Toshima M, Dougherty DA, Foley PL, Lee KS. Effect of U88999E on experimental cerebral vasospasm in rabbits. Neurosurgery. 1993;32(2):281–8. discussion 8.
57. Wanebo JE, Arthur AS, Louis HG, West K, Kassell NF, Lee KS, et al. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Neurosurgery. 1998;43(6):1409–17. discussion 17–8.
58. Bavbek M, Polin R, Kwan AL, Arthur AS, Kassell NF, Lee KS. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke. 1998;29(9):1930–5. discussion 5–6.
59. Bilginer B, Onal MB, Narin F, Soylemezoglu F, Ziyal IM, Ozgen T. The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model. Turk Neurosurg. 2009;19(4):374–9.
60. Cengiz SL, Erdi MF, Tosun M, Atalik E, Avunduk MC, Sonmez FC, et al. Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study. Brain Inj. 2010;24(6):877–85. doi:10.3109/02699051003789260.
61. Cheng G, Chunlei W, Pei W, Zhen L, Xiangzhen L. Simvastatin activates Akt/glycogen synthase kinase-3beta signal and inhibits caspase-3 activation after experimental subarachnoid hemorrhage. Vascul Pharmacol. 2010;52(1–2):77–83. doi:10.1016/j.vph.2009.12.001.
62. Foley PL, Kassell NF, Hudson SB, Lee KS. Hemoglobin penetration in the wall of the rabbit basilar artery after subarachnoid hemorrhage and intracisternal hemoglobin injection. Acta Neurochir (Wien). 1993;123(1–2):82–6.
63. Grieb P, Ryba MS, Sawicki J, Chrapusta SJ. Oral coenzyme Q10 administration prevents the development of ischemic brain lesions in a rabbit model of symptomatic vasospasm. Acta Neuropathol. 1997;94(4):363–8.
64. Hirashima Y, Endo S, Otsuji T, Karasawa K, Nojima S, Takaku A. Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg. 1993;78(4):592–7. doi:10.3171/jns.1993.78.4.0592.
65. Iseda K, Ono S, Onoda K, Satoh M, Manabe H, Nishiguchi M, et al. Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. J Neurosurg. 2007;107(1):128–35. doi:10.3171/JNS-07/07/0128.
66. Kaneko A, Moritake K, Kimura Y. Inhibitory effect of deuterium oxide on cerebral vasospasm after experimental subarachnoid hemorrhage in a rabbit model. Neurol Res. 2005;27(4):446–51. doi:10.1179/016164105X49201.
67. Kiris T, Karasu A, Yavuz C, Erdem T, Unal F, Hepgul K, et al. Reversal of cerebral vasospasm by the nitric oxide donor SNAP in an experimental model of subarachnoid haemorrhage. Acta Neurochir (Wien). 1999;141(12):1323–8. discussion 8–9.
68. Satoh M, Date I, Nakajima M, Takahashi K, Iseda K, Tamiya T, et al. Inhibition of poly(ADP-ribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke. 2001;32(1):225–31.
69. Tanaka Y, Machi T, Nihei H, Kassell NF. Effect of subarachnoid hemorrhage on serotonin uptake and release in the rabbit basilar artery. Neurosurgery. 1991;28(3):387–92. discussion 92–3.
70. Tang WH, Chen Z, Liu Z, Zhang JH, Xi G, Feng H. The effect of ecdysterone on cerebral vasospasm following experimental subarachnoid hemorrhage in vitro and in vivo. Neurol Res. 2008;30(6):571–80. doi:10.1179/174313208X297986.
71. Vorkapic P, Bevan JA, Bevan RD. Longitudinal in vivo and in vitro time-course study of chronic cerebrovasospasm in the rabbit basilar artery. Neurosurg Rev. 1991;14(3):215–9.
72. Kwan AL, Lin CL, Yanamoto H, Howng SL, Kassell NF, Lee KS. Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery. 1998;42(2):347–50. discussion 50–1.
73. Lin CL, Lo YC, Chang CZ, Kwan AL, Chen IJ, Howng SL. Prevention of cerebral vasospasm by a capsaicin derivative, glyceryl nonivamide, in an experimental model of subarachnoid hemorrhage. Surg Neurol. 2001;55(5):297–301.
74. Kertmen H, Gurer B, Yilmaz ER, Arikok AT, Demirci A, Gokyaprak SM, et al. The effect of thiocolchicoside on cerebral vasospasm following experimental subarachnoid hemorrhage in the rabbit. Acta Neurochir (Wien). 2012;154(8):1431–6. doi:10.1007/s00701-012-1420-3.
75. Laslo AM, Eastwood JD, Pakkiri P, Chen F, Lee TY. CT perfusion-derived mean transit time predicts early mortality and delayed vasospasm after experimental subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2008;29(1):79–85. doi:10.3174/ajnr.A0747.
76. Murphy AM, Xenocostas A, Pakkiri P, Lee TY. Hemodynamic effects of recombinant human erythropoietin on the central nervous system after subarachnoid hemorrhage: reduction of microcirculatory impairment and functional deficits in a rabbit model. J Neurosurg. 2008;109(6):1155–64. doi:10.3171/JNS.2008.109.12.1155.
77. Gabikian P, Clatterbuck RE, Eberhart CG, Tyler BM, Tierney TS, Tamargo RJ. Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats. Stroke. 2002;33(11):2681–6.
78. Pan YX, Chen KF, Lin YX, Wu W, Zhou XM, Zhang XS, et al. Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-alpha. J Clin Neurosci. 2013;20(5):726–30. doi:10.1016/j.jocn.2012.09.012.
79. Ahmad I, Imaizumi S, Shimizu H, Kaminuma T, Ochiai N, Tajima M, et al. Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage. Acta Neurochir (Wien). 1996;138(10):1230–40.
80. Kubota Y, Isotani E, Mizuno Y, Ohno K, Azuma H. Alterations of intracellular calcium concentration and nitric oxide generation in pulmonary artery endothelium after subarachnoid hemorrhage of the rabbit. Vascul Pharmacol. 2007;47(2–3):90–8. doi:10.1016/j.vph.2007.04.004.
81. Mizuno Y, Isotani E, Ohno K, Nagai A, Imamura M, Azuma H. Involvement of accumulated NOS inhibitors and endothelin-1, enhanced arginase, and impaired DDAH activities in pulmonary dysfunction following subarachnoid hemorrhage in the rabbit. Vascul Pharmacol. 2008;48(1):21–31. doi:10.1016/j.vph.2007.11.002.
82. Hong T, Wang Y, Wang HT, Wang H. Inhibitory effect of gap junction blockers on cerebral vasospasm. J Neurosurg. 2008;108(3):551–7. doi:10.3171/JNS/2008/108/3/0551.
83. Tsurutani H, Ohkuma H, Suzuki S. Effects of thrombin inhibitor on thrombin-related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model. Stroke. 2003;34(6):1497–500. doi:10.1161/01.STR.0000070424.38138.30.
84. Yanamoto H, Kikuchi H, Okamoto S, Nozaki K. Preventive effect of synthetic serine protease inhibitor, FUT-175, on cerebral vasospasm in rabbits. Neurosurgery. 1992;30(3):351–6. discussion 6–7.
85. Black PM, Tzouras A, Foley L. Cerebrospinal fluid dynamics and hydrocephalus after experimental subarachnoid hemorrhage. Neurosurgery. 1985;17(1):57–62.
86. Tuncer R. Experimental basilar artery spasm caused by autologous blood application: effects of clot removal and topical nicardipine. Acta Neurochir (Wien). 1993;121(1–2):72–5.
87. Yurt A, Ozer F, Selcuki M, Erturk AR, Gorgulu O. Effect of systemic parameters following experimental subarachnoid hemorrhage and cerebral vasospasm in rabbits by injection of blood into the subarachnoidal space. Neurosciences (Riyadh). 2010;15(1):15–20.
88. Ishiguro M, Puryear CB, Bisson E, Saundry CM, Nathan DJ, Russell SR, et al. Enhanced myogenic tone in cerebral arteries from a rabbit model of subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol. 2002;283(6):H2217–25. doi:10.1152/ajpheart.00629.2002.
89. 2+ spark activity after subarachnoid hemorrhage disables BK channel control of cerebral artery tone. J Cereb Blood Flow Metab. 2011;31(1):3–16. doi:10.1038/jcbfm.2010.143.
90. Laslo AM, Eastwood JD, Chen FX, Lee TY. Dynamic CT perfusion imaging in subarachnoid hemorrhage-related vasospasm. AJNR Am J Neuroradiol. 2006;27(3):624–31.
91. Nelson RJ, Perry S, Burns AC, Roberts J, Pickard JD. The effects of hyponatraemia and subarachnoid haemorrhage on the cerebral vasomotor responses of the rabbit. J Cereb Blood Flow Metab. 1991;11(4):661–6. doi:10.1038/jcbfm.1991.118.
92. Otsuji T, Endo S, Hirashima Y, Nishijima M, Takaku A. An experimental model of symptomatic vasospasm induced by oxyhemoglobin in rabbits. Stroke. 1994;25(3):657–62.
93. Taplu A, Gokmen N, Erbayraktar S, Sade B, Erkan N, Karadibak K, et al. Effects of pressure- and volume-controlled inverse ratio ventilation on haemodynamic variables, intracranial pressure and cerebral perfusion pressure in rabbits: a model of subarachnoid haemorrhage under isoflurane anaesthesia. Eur J Anaesthesiol. 2003;20(9):690–6.
94. Marbacher S, Andereggen L, Neuschmelting V, Widmer HR, von Gunten M, Takala J, et al. A new rabbit model for the study of early brain injury after subarachnoid hemorrhage. J Neurosci Methods. 2012;208(2):138–45. doi:10.1016/j.jneumeth.2012.05.010.
95. Liu P, Liao X, Xiang J, Pan L, Ma L. Continuous intravertebral injection of fasudil hydrochloride in the treatment of cerebral vasospasm. Neurol India. 2011;59(2):161–7. doi:10.4103/0028-3886.79127.
96. Kwan AL, Lin CL, Chang CZ, Wu HJ, Hwong SL, Jeng AY, et al. Continuous intravenous infusion of CGS 26303, an endothelin-converting enzyme inhibitor, prevents and reverses cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery. 2001;49(2):422–7. discussion 7–9.
97. Strong MJ, Wolff AV, Wakayama I, Garruto RM. Aluminum-induced chronic myelopathy in rabbits. Neurotoxicology. 1991;12(1):9–21.
98. Kusaka G, Kimura H, Kusaka I, Perkins E, Nanda A, Zhang JH. Contribution of Src tyrosine kinase to cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2003;99(2):383–90. doi:10.3171/jns.2003.99.2.0383.
99. Zhou C, Yamaguchi M, Kusaka G, Schonholz C, Nanda A, Zhang JH. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24(4):419–31. doi:10.1097/00004647-200404000-00007.
100. Kim CY, Paek SH, Seo BG, Kim JH, Han DH. Changes in vascular responses of the basilar artery to acetylcholine and endothelin-1 in an experimental rabbit vasospasm model. Acta Neurochir (Wien). 2003;145(7):571–7. doi:10.1007/s00701-003-0024-3.
101. Aydin MD, Kanat A, Yilmaz A, Cakir M, Emet M, Cakir Z, et al. The role of ischemic neurodegeneration of the nodose ganglia on cardiac arrest after subarachnoid hemorrhage: an experimental study. Exp Neurol. 2011;230(1):90–5. doi:10.1016/j.expneurol.2010.09.018.
102. Gurelik M, Kayabas M, Karadag O, Goksel HM, Akyuz A, Topaktas S. Cervical spinal cord stimulation improves neurological dysfunction induced by cerebral vasospasm. Neuroscience. 2005;134(3):827–32. doi:10.1016/j.neuroscience.2005.04.062.
103. 2+ channels and basilar artery contraction in rabbits. J Neurosurg. 2006;105(2):288–93. doi:10.3171/jns.2006.105.2.288.
104. Zhang Z, Nagata I, Kikuchi H, Xue JH, Sakai N, Sakai H, et al. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB. Stroke. 2001;32(7):1665–72.
105. Echigo R, Shimohata N, Karatsu K, Yano F, Kayasuga-Kariya Y, Fujisawa A, et al. Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage. J Transl Med. 2012;10:80. doi:10.1186/1479-5876-10-80.